CHATSWORTH, Calif., Sept. 22, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that The Wall Street Transcript (TWST) has published an in-depth interview with Chairman, President and Chief Executive Officer Cesar Garcia. The interview, which was published in the September 20 Medical Devices issue of TWST, is available in its entirety on the IRIS web site at www.proiris.com/interview, or to subscribers at TWST's web site (www.twst.com).
